Instil Bio, Inc. (TIL) Live Share Price, Invest From India

Instil Bio, Inc. Stock Performance

as on January 9, 2026 at 2:29 am IST

Day's Low
Day's High
$6.77
Day's Price Range
$7.42
$7.38
8.27%
Downside
0.54%
Upside
52 Week's Low
52 Week's High
$5.67
52-Week Price Range
$42.79
$7.38
23.17%
Downside
479.81%
Upside

Instil Bio, Inc. share price movements today

Previous Close: $7.18
Open: $7.08
Volume: 744.7K
Day's Low - High: $6.77 - $7.42
52 Week Low - High: $5.67 - $42.79

Instil Bio, Inc. Historical Returns

1 Month Return: -33.06 %
3 Month Return: -64.39 %
1 Year Return: -66.41 %
3 Year Return: -44.85 %
5 Year Return: 0 %

Instil Bio, Inc. Stock Fundamentals & Key Indicators

Check Instil Bio, Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$48.7M

EPS (TTM)

-11.51

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

PEG Ratio

EBITDA

-56.5M

Revenue (TTM)

Profit Margin

0.00%

Return On Equity TTM

-50.60%

Instil Bio, Inc. stock Key Stats

Compare market cap, revenue, PE, and other key metrics of Instil Bio, Inc. with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Instil Bio, Inc.	BUY	$48.7M	NA	NA	0.00%

Stock Returns calculator for Instil Bio, Inc. Stock including INR - Dollar returns

The Instil Bio, Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Instil Bio, Inc. investment value today

Current value as on today

₹38,435

Returns

₹61,565

(-61.57%)

Returns from Instil Bio, Inc. Stock

₹66,455 (-66.45%)

Dollar Returns*

₹4,889 (+4.89%)

Analyst Recommendation on Instil Bio, Inc. Stock

Based on 7 analysts

BUY

71.43%

Buy

28.57%

Hold

0.00%

Sell

Based on 7 analysts, 71.43% of analysts recommend a 'BUY' rating for Instil Bio, Inc.. Average target price of $29

Instil Bio, Inc. Share Price Target

Get share price movements and forecasts by analysts on Instil Bio, Inc..

What analysts predicted

74.55%UPSIDE

Target Price

$29

Current Price

$7.38

Analyzed by

7 Analysts

Target

$29.00

Instil Bio, Inc. target price $29, a slight upside of 74.55% compared to current price of $7.38. According to 7 analysts rating.

Instil Bio, Inc. Stock’s Investor Sentiment and Interest

Investment in Instil Bio, Inc. Shares on INDmoney has grown by 1216.66% over the past 30 days, indicating increased transactional activity.

Time period: December 10, 2025 to January 9, 2026

Change:1216.66% versus previous 30 day period

Search interest for Instil Bio, Inc. Stock has increased by 3133% in the last 30 days, reflecting an upward trend in search activity.

Time period: December 10, 2025 to January 9, 2026

Change:3133% versus previous 30 day period

Instil Bio, Inc. Quarterly Profit & Loss

All numbers in Millions USD

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025
Total Revenue	-	-	7	-	-	-	3	-	-	-
Gross Profit	0	0	-1	0	-1	0	0	0	0	0
Operating Income	-20	-66	-12	-19	-14	-23	-11	-30	-23	-15
EBITDA	-17	-64	-9	-21	-11	-20	-8	-26	-19	-11
Interest Expense	0	2	1	1	1	2	2	1	1	1
Depreciation	0	0	1	0	0	0	0	0	0	0
Income Before Tax	-18	-67	-12	-24	-14	-23	-11	-28	-21	-13
Income Tax Expense	0	0	1	0	-	-	0	-	-	-
Net Income	-18	-67	-12	-24	-14	-23	-11	-28	-21	-13
Net Profit Margin	0.00%	0.00%	-168.51%	0.00%	0.00%	0.00%	-298.42%	0.00%	0.00%	0.00%

Instil Bio, Inc. Annual Profit & Loss

All numbers in Millions USD

	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Revenue	-	0	-	-	-	-
Gross Profit	0	0	-2	-5	-4	-3
Operating Income	-6	-33	-155	-206	-159	-73
EBITDA	-6	-33	-152	-217	-147	-62
Interest Expense	-	3	1	1	5	8
Depreciation	0	0	2	5	5	3
Income Before Tax	-6	-37	-156	-225	-156	-74
Income Tax Expense	0	0	0	-2	-	-
Net Income	-6	-37	-156	-223	-156	-74
Net Profit Margin	0.00%	-27346.38%	0.00%	0.00%	0.00%	0.00%

Instil Bio, Inc. Quarterly Cash Flow

All numbers in Millions USD

	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025
Net Income	-67	-12	-24	-14	-23	-11	-28	-21	-13
Operating Cash Flow	-14	-13	-14	-10	-20	-10	-4	-14	-10
Investing Cash Flow	2	13	9	11	19	13	9	0	8
Financing Cash Flow	0	1	-	-	0	1	0	6	0
Change in Cash	-12	1	-5	1	0	3	5	-8	-1

Instil Bio, Inc. Annual Cash Flow

All numbers in Millions USD

	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Net Income	-37	-156	-223	-156	-74
Operating Cash Flow	-29	-122	-180	-82	-55
Investing Cash Flow	-51	-474	114	41	53
Financing Cash Flow	313	393	71	8	1
Change in Cash	232	-203	5	-33	0

Global Institutional Holdings in Instil Bio, Inc.

Funds	Holdings
BML Capital Management LLC	7.92%
Siren, L.L.C.	3.02%
Dimensional Fund Advisors, Inc.	1.23%
Assenagon Asset Management SA	0.85%
Trexquant Investment LP	0.26%

See all

Insights on Instil Bio, Inc.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Revenue Rich
Revenue is up for the last 2 quarters, 70.71 Cr → 81.45 Cr (in ₹), with an average increase of 13.2% per quarter
POSITIVE IMPACT
Retail Holding Up
Retail Investor have increased holdings from 30.37% to 30.42% in Sep 2025 quarter
NO EFFECT
Against Peers
In the last 3 years, Jupiter Wagons Ltd has given 206.9% return, outperforming this stock by 160.8%
NO EFFECT
Against Peers
In the last 1 year, Ashok Leyland Ltd has given 72.1% return, outperforming this stock by 87.0%
NO EFFECT
Promoter Holding Unchanged
Promoters holdings remained unchanged at 68.43% of holdings in Sep 2025 quarter
NO EFFECT
Against Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 30.3% return, outperforming this stock by 75.2%
NO EFFECT
Against Peers
In the last 1 year, Beone Medicines Ltd has given 80.1% return, outperforming this stock by 146.5%
NEGATIVE IMPACT
Price Dip
In the last 6 months, TIL stock has moved down by -33.5%
NEGATIVE IMPACT
FII Holding Down
Foreign Institutions have decreased holdings from 0.09% to 0.04% in Sep 2025 quarter
NEGATIVE IMPACT
Profit Down
Netprofit is down for the last 3 quarters, 9.76 Cr → -7.73 Cr (in ₹), with an average decrease of 94.0% per quarter
NEGATIVE IMPACT
Price Dip
In the last 7 days, TIL stock has moved down by -34.4%

About Instil Bio, Inc.

instil bio is a cell therapy company developing tumor infiltrating lymphocytes (til) for the treatment of solid tumor cancers. til are a patient’s own t cells harvested from the patient’s tumor, which are then expanded and reinfused into the patient to target and kill cancer cells. the company is advancing its proprietary manufacturing expertise, technology, and data into clinical trials, including a planned registrational study with its lead candidate and a first-in-human study of its next-generation engineered til. the company is led by world-class cell therapy experts and backed by premier global institutional investors. instil is located in the greater los angeles area with additional manufacturing and research facilities in manchester, uk.

Organisation	Instil Bio, Inc.
Headquarters	3963 Maple Avenue, Dallas, TX, United States, 75219
Industry	Healthcare
CEO	Mr. Bronson Crouch
E-voting on shares	Click here to vote

Key Management of Instil Bio, Inc.

Name	Title
Mr. Bronson Crouch	Chairman & CEO
Dr. Sandeep Laumas M.D.	CFO & Chief Business Officer
Dr. James Freedman M.D., Ph.D.	Chief Medical Officer
Dr. Qiying Lu M.D.	Chief Medical Officer & Senior VP of China

FAQs

What is Instil Bio, Inc. share price today?

Instil Bio, Inc. share price today is $7.38 as on January 9, 2026 at 2:29 am IST at the close of the market. Instil Bio, Inc. share today touched a day high of $7.42 and a low of $6.77.

What is the 52 week high and 52 week low for Instil Bio, Inc. share?

Instil Bio, Inc. share touched a 52 week high of $42.79 on June 10, 2025 and a 52 week low of $5.67 on January 6, 2026. Instil Bio, Inc. stock price today i.e. January 9, 2026 at 2:29 am IST is closed at $7.38,which is 82.75% down from its 52 week high and 30.16% up from its 52 week low.

What is Instil Bio, Inc.'s market capitalisation today?

Instil Bio, Inc. market capitalisation is $0.00T as on January 9, 2026 at 2:29 am IST.

How to invest in Instil Bio, Inc. Stock (TIL) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Instil Bio, Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Instil Bio, Inc. Shares that will get you 0.2033 shares as per Instil Bio, Inc. share price of $7.38 per share as on January 9, 2026 at 2:29 am IST.

What is the minimum amount required to buy Instil Bio, Inc. Stock (TIL) from India?

Indian investors can start investing in Instil Bio, Inc. (TIL) shares with as little as ₹90.123 or $1 (as of January 9, 2026 at 5:39 pm IST) using the INDmoney app.
For example: If you want to invest $10 or ₹901.23 in Instil Bio, Inc. stock (as per the Rupee-Dollar exchange rate as on January 9, 2026 at 5:39 pm IST). Based on Instil Bio, Inc. share’s latest price of $7.38 as on January 9, 2026 at 2:29 am IST, you will get 1.3550 shares of Instil Bio, Inc.. Learn more about fractional shares .